David Kramer: The first US production in 30 years of molybdenum-99, the parent isotope of the most widely used medical radioisotope, is expected to begin within weeks after federal regulators approved a manufacturing process developed by Wisconsin-based NorthStar Medical Radioisotopes. NorthStar received $25 million in matching funds from DOE for development of the neutron capture process and $14.8 million of an expected $25 million total for its accelerator approach.
Latest from John Shanahan
- GEH receives federal funds for BWRX-300 development (World Nuclear News) USofA
- Rejecting carbon colonialism (Paul Driessen, David Wojick, CFACT) USofA
- Move Beyond the Linear No-Threshold Theory for Low-Dose Radiation (J Cardarelli II, B Ulsh) USofA
- Man-made contributions to global warming (Ed Berry) USofA
- Wind Energy in Germany (Edgar Ocampo Tellez) Mexico